(Q33841658)

29 July 2017

1 reference

title

In situ use of suicide genes for therapy of brain tumours (English)

1 reference

29 July 2017

0 references

Wildner O

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

31

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

421-429

1 reference

Brain metastases: 1995. A brief review

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Reoperation in the treatment of recurrent intracranial malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Migration of genetically labeled glioma cells after implantation into murine brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Presence of immunosuppressive factors in brain-tumor cyst fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Ganciclovir. An update of its therapeutic use in cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Potential of Varicella zoster virus thymidine kinase as a suicide gene in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Selection against expression of the Escherichia coli gene gpt in hprt+ mouse teratocarcinoma and hybrid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

An adenovirus vector for gene transfer into neurons and glia in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Adenovirus-mediated gene therapy of experimental gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Immune responses to adenovirus vectors in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Gene transfer to brain using herpes simplex virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

A Phase I/II Study of Herpes Simplex Virus Type 1 Thymidine Kinase “Suicide” Gene Therapy for Recurrent Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899908998799

10.3109/07853899908998799

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference